Aeterna Zentaris completes key phase of DETECT trial By Investing.com by Technical Terrence Team 06/13/2024 0 Aeterna Zentaris Inc. (NASDAQ:), a biopharmaceutical company specializing in endocrine-related therapeutics and diagnostics, today announced the completion of the final ...
Rise Vision Introduces New Screen Sharing Feature to Improve Collaboration and Interaction 09/17/2024